Scopia Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Scopia Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-41,945	Closed	-$755K	–	25
2020 Q2	$755K	Sell	41,945 -18,444	-31%	-$257K	0.08%	20
2020 Q1	$431K	Buy	+60,389	New	+$754K	0.04%	25
2015 Q2	–	Sell	-980,700	Closed	-$37.2M	–	41
2015 Q1	$37.2M	Sell	980,700 -50,326	-5%	-$1.73M	0.81%	23
2014 Q4	$29.2M	Buy	+1,031,026	New	+$28.7M	0.54%	25

Scopia Capital Management's PTLA Position: Q3 2020 in Review

Scopia Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 41,945 shares — an estimated $755K sold.

Scopia Capital Management first reported a position in PTLA in Q4 2014 and held it in 4 quarters. The position peaked at $37.2M in Q1 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Scopia Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Scopia Capital Management sold 41,945 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $755K.
Scopia Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
Scopia Capital Management's Portola Pharmaceuticals, Inc. position peaked at $37.2M in Q1 2015.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Scopia Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.